Publish a course
Contact us
Français
English
English
Log in
Home
/
Profile
Dr. Laurence Escalup

Overview

Dr Laurence Escalup is a pharmacist and the Head of the Pharmacy department at Institut Curie, Paris, France. She specializes in Oncology care : pharmacotechnology, clinical oncology & clinical research. She is an active member of national & international working groups for the improvement of pharmaceutical aspects related to the care of oncology patients.

Source : Institut Curie
Paris, France
Pharmacist
French  /  English

Videos

Work Experience

Pharmacist & Head of Department Pharmacy Department
Since 2013
Institut Curie, Paris, France

Pubmed

First-line Bevacizumab and Paclitaxel for HER2-negative Metastatic Breast Cancer: A French Retrospective Observational Study.
2017
Anticancer research Read it here Costs associated with Eribulin treatment for patients with metastatic breast cancer in a comprehensive cancer center in France.
2016
Breast (Edinburgh, Scotland) Read it here Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer.
2015
Annals of oncology : official journal of the European Society for Medical Oncology Read it here
View more

Professional Associations

ADIPH Member
Get updated Receive the latest news from Dr. Laurence Escalup
Are you a Healthcare professional?
Speciality
Email
Pubmed First-line Bevacizumab and Paclitaxel for HER2-negative Metastatic Breast Cancer: A French Retrospective Observational Study.
2017
Anticancer research Read it here Costs associated with Eribulin treatment for patients with metastatic breast cancer in a comprehensive cancer center in France.
2016
Breast (Edinburgh, Scotland) Read it here Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer.
2015
Annals of oncology : official journal of the European Society for Medical Oncology Read it here Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trial.
2014
British journal of cancer Read it here Long-term physico-chemical stability of diluted trastuzumab.
2013
International journal of pharmaceutics Read it here Dose standardisation of anticancer drugs.
2011
International journal of clinical pharmacy Read it here Platinum-based chemotherapy in metastatic triple-negative breast cancer: the Institut Curie experience.
2011
Annals of oncology : official journal of the European Society for Medical Oncology Read it here Chemical sterilization with peracetic acid: permeation risks inside parenteral infusion fluid.
2001
PDA journal of pharmaceutical science and technology Read it here

Join Invivox

Already have an account? Log in
Or create your account with your email address
Email

Create your password

Password
Show
Your password must contain
One uppercase character
A special character
8 characters minimum
Press ENTER

Choose your specialty

Speciality
Press ENTER
Choose your specialty
Speciality
Press ENTER
Log in
Don’t have an account yet? Create your account
Or log in with your email address
Email
Password
Forgot your password?
Reset Password
Enter the email address associated with your account, and we’ll email you a link to reset your password.
Email Address
Don’t have an account yet? Create your account
Create your password
Password
Show
Your password must contain
One lowercase character
One uppercase character
8 characters minimum
Press ENTER
By clicking Save I hereby confirm that I have read and accept the General Terms & Conditions applicables to the use of invivox.com. For more information, please see our Privacy policy.